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Reply
Weappreciate the interest ofDr. Thomas and colleagues in our work (1).
Our goal was not so much to produce a new score, but to
propose strain as a guide for the assessment of right ventricular
(RV) function. Evaluating the RV in these circumstances seems
like a rational step: the recognition of severe RV dysfunction might
reasonably lead the clinician to opt for a biventricular device in the
first instance. However, evaluation of the RV remains challenging,
and our observation is that strain, as a geometry-independenttechnique, avoids the limitations of the typical RV measures.
Perhaps because of this, it is more predictive of RV failure than
standard measures. However, as an ejection-phase marker, strain is
load dependent: in this population, the correlation between RV
strain and afterload (mean pulmonary artery pressure, r  0.16)
was greater than that with pre-load (right atrial pressure, r 0.03).
iven the elevation of both of these markers in almost all patients,
t is possible that the responses of RV strain to manipulations in
re-load, afterload, or contractility would add additional predictive
alue, but we did not test this.
There were 3 barriers to the study of elective biventricular
evices. First, insufficient numbers were available to address this
uestion, which probably requires a multicenter study to obtain
ufficient numbers of patients. Second, most of these patients were
n extracorporeal membrane oxygenation, which has a major
nfluence on attempted RV function measurement. Third, a study
esign to show the value of RV evaluation is difficult in patients
ith biventricular devices; certainly, the chosen endpoint has no
eaning in these patients.
The multiplicity of prognostic scores in the ventricular assist
evice literature is perhaps a reflection of the fact that some
pisodes of RV failure are due to bleeding, RV ischemia, and
ccidental mechanical damage to the RV, as Dr. Jorde et al.
ropose. These are unpredictable events that compromise the
erformance of any score. Notwithstanding the role of unpredict-
ble contributors, RV strain seems to be a useful factor when
onsidering the possible contributors to RV dysfunction in this
opulation.
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